Stay updated on Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.

Latest updates to the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page
- Check2 days agoChange DetectedThe page’s revision tag was updated from v3.6.0 to v3.6.2. This indicates a newer version of the page's metadata rather than a substantive change to the study details.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a notice that the study is no longer looking for participants, clarifying that recruitment has ceased and potential participants should not enroll. The update also adds user-facing guidance sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and adjusts the Intervention/Treatment header formatting along with showing a new revision version (v3.6.0).SummaryDifference0.3%

- Check23 days agoChange DetectedThe page revision indicator was updated from v3.5.4 to v3.5.5, representing a new build of the ClinicalTrials.gov page. No trial content or data appear to be affected.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page now displays the revision label as v3.5.4, replacing the previous v3.5.3. This change signals a newer release of the site’s components and may reflect updates to the underlying platform used by the page.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page’s footer software/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3.”SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.5.2 supersedes v3.5.0 on the page.SummaryDifference0.0%

Stay in the know with updates to Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.